Clinical Trials Browser

Interventional × Breast Neoplasms × reolysin × Clear all

NCT04215146 2025-01-16

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Phase 2 Active not recruiting

48 enrolled 13 charts

Breast Neoplasms

NCT05519059 2023-11-22

Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms

NCT01656538 2023-08-04

A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT04102618 2022-08-15

AWARE-1

Phase EARLY_PHASE1 Terminated

Breast Neoplasms, Triple Negative Breast Neoplasms